Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | primaquine | 26596 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | primaquine | 26596 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | primaquine | 26596 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | primaquine | 26596 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | primaquine | 26596 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | primaquine | 26596 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | naringenin | 3783 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | naringenin | 3783 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | naringenin | 3783 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | naringenin | 3783 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | naringenin | 3783 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | naringenin | 3783 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | naringenin | 3783 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | naringenin | 3783 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | naringenin | 3783 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | naringenin | 3783 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | naringenin | 3783 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | naringenin | 3783 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | naringenin | 3783 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | naringenin | 3783 | drug-path |